The language used by US Food and Drug Administration (FDA) commissioner Scott Gottlieb to describe youth vaping is getting stronger. What he formerly called an “epidemic” has become a “tragedy” in his first statement on the issue since Altria announced they would stop selling e-cigarette pods and many flavours.
Gottlieb today described as “constructive” recent meetings with Juul Labs, Altria, Reynolds American, Fontem Ventures and Japan Tobacco International. The meetings followed letters sent by the FDA on 12th October to 21 manufacturers and importers requesting information on more than 40 products.
The commissioner said the company’s proposals were “thoughtful”. And he added: “We’re committed to announcing a new action plan by mid-November that will set forth a series of new, forceful steps to firmly confront and reverse the youth addiction trends that are at epidemic levels.”
...
Restricted content. Do you want to read more?
Register
Sign up NOW for 7 days FREE TRIAL and access our briefings section
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.